SUNIMUD Study: Sunphenon EGCg (epigallocatechin gallate) in Duchenne type muscular dystrophy
In this study, which was carried out in close cooperation with the Social Pediatric Center (SPZ) for Neuropediatrics at the Charité-Campus Virchow Klinikum (CVK) and the Clinic for Child and Adolescent Medicine of the DRK Kliniken Berlin Westend, we investigated whether the regular taking of the extract of green tea (epigallocatechin gallate, EGCG) positively influences the progression of disability of patients with Duchenne muscular dystrophy. This is a multi-center, randomized, placebo-controlled, double-blind study. Participation was open to male patients from the age of five who have been diagnosed with Duchenne muscular dystrophy. The study medicine was taken twice a day as a capsule.
Study Director: Prof. Dr. Friedemann Paul (WG Clinical Neuroimmunology, NCRC, ECRC), Dr. Ulrike Grieben (SPZ, Pediatrics)
Course of the study: 12/2010 - 09/2018
The study is registered in the database clinicaltrials.gov (NCT01183767).